Abstract:Objective To investigate the role of transcription factor peroxisome proliferator-activated receptor-gamma coactivator-1 beta (PGC-1β) on osteoclastogenesis and related regulatory mechanism in the mouse monocyte-macrophage cell line (RAW264.7).Methods PGC-1β expression and location in RAW264.7 cells was detected by immunofluorescence,flow cytometry and western blot analysis with nuclear protein extraction.RAW264.7 cells were transfected with lentivirus for gene silencing or over-expression of PGC-1β and cultured with macrophage colony-stimulating factor and receptor activator for nuclear factor-κB ligand.Cell viability was detected by cell counting kit-8.Cell apoptosis and cell cycle were detected by flow cytometry.Mature osteoclasts and their bone resorption activity were determined by tartrate-resistant acid phosphatase (TRAP) expression and toluidine blue staining.Western blot analysis was performed for detecting dendritic cell-specific transmembrane protein (DC-STAMP),cathepsin K,TRAP and matrix metalloproteinase (MMP)-9 expression,as well as cytoplasmic NF-κB-inducing kinase (NIK) and nuclear RelB.Results PGC-1β expression was observed in the nuclei of RAW264.7 cells.Down-regulation or overexpression of PGC-1β in RAW264.7 cells did not affect cell viability,apoptosis or cell cycle.Down-regulation of PGC-1β decreased the count of mature osteoclasts (49±21 cells vs.147±42 cells,P=0.004) and the pit area of bone resorption lacunae (42.11 μm2 ± 11.30 μm2 vs.204.80μm2 ± 31.09 μm2,P＜0.001),as well as the expression of cathepsin K,TRAP and MMP-9,but not DC-STAMP.Overexpression of PGC-1β promoted osteoclast differentiation and bone resorption activity,as well as the expression of cathepsin K,TRAP and MMP-9.Down-regulation of PGC-1β suppressed the protein expression of cytoplasmic NIK and nuclear RelB in RAW264.7 cells.Conclusion PGC-1β can promote the differentiation of RAW264.7 into osteoclasts and improve the bone resorption ability of the cells via activation of NIK/RelB pathway,which might be a promising therapeutic target for osteoporosis.

PPAR‐γ Agonist Pioglitazone Alleviates Inflammatory Response Induced by Lipopolysaccharides in Osteoblast Cells

PPAR-<i></i> Activation Alleviates Osteoarthritis through Both the Nrf2/NLRP3 and PGC-1<i></i>/<i></i><sub>m</sub> Pathways by Inhibiting Pyroptosis

PPARγ Agonist Pioglitazone Inhibits Microglia Inflammation by Blocking P38 Mitogen-Activated Protein Kinase Signaling Pathways

Activation of peroxisome proliferator-activated receptor-gamma potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge

Activation of Peroxisome Proliferator-Activated Receptor-Γ Potentiates Pro-Inflammatory Cytokine Production, and Adrenal and Somatotropic Changes of Weaned Pigs after Escherichia Coli Lipopolysaccharide Challenge

PPAR-γ Activation Alleviates Osteoarthritis through Both the Nrf2/NLRP3 and PGC-1α/Δψm Pathways by Inhibiting Pyroptosis

[Anti-Inflammatory Effect of Peroxisome Proliferator-Activated Receptor-Gamma Incultured Human Mesangial Cells].

Anti-Inflammatory Effect Of Ppar Gamma In Cultured Human Mesangial Cells

Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways

Effects of pioglitazone on differentiation and function of cultured osteoclast-like cells of rats

Potential mechanism of transcription factor peroxisome proliferator-activated receptor-gamma coactivator-1 beta on promoting osteoclastogenesis

Upregulation of PGC-1α expression by pioglitazone mediates prevention of sepsis-induced acute lung injury

SUMOylation of PPARγ by Rosiglitazone Prevents LPS-Induced NCoR Degradation Mediating Down Regulation of Chemokines Expression in Renal Proximal Tubular Cells

Peroxisome proliferator-activated receptor γ prevents the production of NOD-like receptor family, pyrin domain containing 3 inflammasome and interleukin 1β in HK-2 renal tubular epithelial cells stimulated by monosodium urate crystals

Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis

Effect of PPARγ on the Analgesic Effects of Pioglitazone

The Role of PPARγ in Advanced Glycation End Products-Induced Inflammatory Response in Human Chondrocytes.

Peroxisome Proliferator-Activated Receptor-Γ Agonists Suppress Inos Expression Induced by LPS in Rat Primary Schwann Cells

PPAR-gamma Ligands Inhibit the Expression of Inflammatory Cytokines and Attenuate Autoimmune Myocarditis.

Inhibitory Effect of Peroxisome Proliferator Activated Receptor γ Ligands on Secretion of Inflammatory Cytokine and Matrix Metalloproteinase in Macrophages and Foam Cell

PPARγ Attenuates Interleukin-1β-Induced Cell Apoptosis by Inhibiting NOX2/ROS/p38MAPK Activation in Osteoarthritis Chondrocytes.